• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by National Healthcare Properties Inc.

    5/15/26 4:06:14 PM ET
    $NHP
    Get the next $NHP alert in real time by email
    S-8 1 nhp-sx8.htm S-8 Document

    As filed with the Securities and Exchange Commission on May 15, 2026
    Registration No. 333-          
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    National Healthcare Properties, Inc.
    (Exact name of registrant as specified in its charter)
    Maryland
    (State or other jurisdiction of incorporation or organization)
    38-3888962
    (IRS Employer Identification Number)
    540 Madison Ave., 27th Floor, New York, NY10022
    (Address of principal executive offices)(Zip code)
    2025 Omnibus Incentive Compensation Plan of National Healthcare Properties, Inc.
    (Full title of the Plan)
    Michael Anderson
    Chief Executive Officer and President
    National Healthcare Properties, Inc.
    540 Madison Ave, 27th Floor
    New York, NY 10022
    (Name and address of agent for service)
    (332) 258-8770
    (Telephone number, including area code, of agent for service)
    Copies to:
    Joseph A. Herz, Esq.
    Win Rutherfurd, Esq.
    Greenberg Traurig, LLP
    One Vanderbilt Avenue
    New York, New York 10017
    Tel: (212) 801-9200
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer
    ☐
    Accelerated filer
    ☐
    Non-accelerated filer☒Smaller reporting company
    ☐
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



    STATEMENT OF INCORPORATION BY REFERENCE
    This Registration Statement is being filed by National Healthcare Properties, Inc. (the “Company”) to register an additional 2,877,875 shares of common stock, $0.01 par value per share (“Common Stock”), reserved for issuance pursuant to the 2025 Omnibus Incentive Compensation Plan (the “Plan”). These shares of Common Stock are of the same class as other securities for which Registration Statement on Form S-8 (File No. 333-287527) was filed by the Company with the Securities and Exchange Commission on May 22, 2025 (the “Prior Registration Statement”).
    Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement are incorporated by reference into this Registration Statement, and the information required by Form S-8 is omitted, except that the provisions contained in Part II of the Prior Registration Statement are modified as set forth in this Registration Statement.



    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3. Incorporation of Documents by Reference.
    The following documents, which the Company has previously filed with the Commission, are hereby incorporated by reference into this registration statement (excluding any information that is deemed to have been “furnished” and not “filed” with the Commission, including any Item 2.02 or Item 7.01 of any Current Report on Form 8-K):
    •The Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Commission on February 20, 2026;
    •The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the Commission on May 14, 2026;
    •The Company’s Definitive Proxy Statement on Schedule 14A, filed with the Commission on March 31, 2026 (solely to the extent incorporated by reference into Part III of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025);
    •The Company’s Current Reports on Form 8-K, filed with the Commission on January 12, 2026 (other than Item 7.01 thereof), April 13, 2026 (other than Items 2.02 and 7.01 thereof), April 27, 2026, May 1, 2026 and May 8, 2026; and
    •The description of the Company’s common stock, par value $0.01 per share (“common stock”), included in the Company’s Registration Statement on Form 8-A, filed with the Commission on April 30, 2014, including any amendment or report filed for the purpose of updating such description, including the description of the common stock filed as Exhibit 4.8 to the Company’s Annual Report on Form 10-K, filed with the Commission on February 20, 2026.
    In addition, all documents and reports subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (excluding any information that is deemed to have been “furnished” and not “filed” with the Commission, including any Items 2.02, 7.01 or 9.01 of any Current Report on Form 8-K), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part hereof from the date of filing of such documents or reports. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.



    Item 8. Exhibits.
    See attached Exhibit Index.
    EXHIBIT INDEX
    Exhibit NoDescription
    4.1
    Composite Articles of Amendment and Restatement for the Company (filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the Commission on November 12, 2024 and incorporated by reference herein)
    4.2
    Articles Supplementary of the Company declassifying our Board, dated January 12, 2026 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on January 12, 2026 and incorporated by reference herein).
    4.3
    Articles Supplementary of the Company prohibiting future election to be subject to Section 3-803 of the MGCL, dated January 12, 2026 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on January 12, 2026 and incorporated by reference herein).
    4.4
    Articles Supplementary relating to the designation of shares of Class A Common Stock, dated April 10, 2026 (filed as an exhibit to the Company’s Registration Statement on Form S-11 filed with the SEC on April 13, 2026 and incorporated by reference herein)
    4.5
    Amended and Restated Bylaws of the Company (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on January 12, 2026 and incorporated by reference herein).
    4.6
    2025 Omnibus Incentive Compensation Plan of National Healthcare Properties, Inc. (filed as an exhibit to the Company’s Registration Statement on Form S-8, filed with the SEC on May 22, 2025 and incorporated by reference herein).
    5.1 *
    Opinion of Venable LLP regarding legality of securities being registered
    23.1 *
    Consent of Venable LLP (included in Exhibit 5.1)
    23.2 *
    Consent of PricewaterhouseCoopers LLP
    24.1 *
    Power of Attorney (included on signature page hereto)
    107 *
    Filing Fee Table
    ________________
    *Filed herewith



    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on May 15, 2026.
    National Healthcare Properties, Inc.
    By:/s/ Michael Anderson
    Name:Michael Anderson
    Title:Chief Executive Officer and President
    POWER OF ATTORNEY
    Each person whose signature appears below hereby constitutes and appoints Michael Anderson and Andrew T. Babin as her or his attorneys-in-fact and agent, with full power of substitution and resubstitution, for her or him in any and all capacities, in connection with this Registration Statement on Form S-8 (the “Registration Statement”) of National Healthcare Properties, Inc., under the Securities Act of 1933, as amended (the “Securities Act”) relating to the 2025 Omnibus Incentive Compensation Plan of National Healthcare Properties, Inc., including, without limiting the generality of the foregoing, to sign any amendments and supplements relating to the Registration Statement (including post-effective amendments) under the Securities Act and to sign any instrument, contract, document or other writing of or in connection with any amendments and supplements relating to the Registration Statement (including post-effective amendments) and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or her or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
    SignaturesTitleDate
    /s/ Michael AndersonDirector, Chief Executive Officer and President (Principal Executive Officer)May 15, 2026
    Michael Anderson
    /s/ Andrew T. BabinChief Financial Officer and Treasurer (Principal Financial Officer)May 15, 2026
    Andrew T. Babin
    /s/ Ailin ParkChief Accounting Officer (Principal Accounting Officer)May 15, 2026
    Ailin Park
    /s/ Leslie D. MichelsonNon-Executive ChairMay 15, 2026
    Leslie D. Michelson
    /s/ Elizabeth K. TuppenyIndependent DirectorMay 15, 2026
    Elizabeth K. Tuppeny
    /s/ B.J. PennIndependent DirectorMay 15, 2026
    B.J. Penn
    /s/ Scott W. HumphreyIndependent DirectorMay 15, 2026
    Scott W. Humphrey
    /s/ Edward M. Weil, Jr.DirectorMay 15, 2026
    Edward M. Weil, Jr.

    Get the next $NHP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NHP

    DatePrice TargetRatingAnalyst
    5/28/2026$18.00Mkt Outperform
    Citizens
    5/18/2026Sector Weight
    KeyBanc Capital Markets
    5/18/2026$15.00Sector Perform
    RBC Capital Mkts
    5/18/2026$17.00Market Perform
    BMO Capital Markets
    5/18/2026$17.00Outperform
    Robert W. Baird
    5/18/2026$16.00Equal-Weight
    Morgan Stanley
    5/18/2026$20.00Buy
    Goldman
    More analyst ratings

    $NHP
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by National Healthcare Properties Inc.

    SCHEDULE 13G - National Healthcare Properties, Inc. (0001561032) (Subject)

    6/1/26 5:19:13 PM ET
    $NHP

    SEC Form SCHEDULE 13G filed by National Healthcare Properties Inc.

    SCHEDULE 13G - National Healthcare Properties, Inc. (0001561032) (Subject)

    5/18/26 5:06:47 PM ET
    $NHP

    SEC Form SC TO-I filed by National Healthcare Properties Inc.

    SC TO-I - National Healthcare Properties, Inc. (0001561032) (Subject)

    5/18/26 9:28:01 AM ET
    $NHP

    $NHP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    National Healthcare Properties Provides Business Updates

    Growing SHOP Acquisition PipelineAddition to the Russell 2000 and 3000 IndexesPresentation at Nareit's REITweek 2026 Investor Conference NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHP) (the "Company"), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today provided the following business updates: SHOP Acquisitions & Pipeline The Company currently has signed purchase and sale agreements or non-binding letters of intent for approximately $279 million

    6/1/26 8:30:00 AM ET
    $NHP

    National Healthcare Properties Announces Tender Offers

    NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHP) (the "Company"), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today announced its concurrent but separate offers to purchase up to a maximum aggregate purchase price in cash of $100 million (the "Maximum Aggregate Purchase Amount") of (i) its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the "Series A Shares"), for a purchase price of $22.50 per share in c

    5/18/26 8:00:00 AM ET
    $NHP

    National Healthcare Properties Reports First Quarter 2026 Results

    NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHP) (the "Company"), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today announced results for the quarter ended March 31, 2026. Michael Anderson, Chief Executive Officer and President, commented, "Our IPO marks the culmination of years of work to position this Company for growth and is just the beginning of what comes next. We are highly confident in our ability to create shareholder value by executing o

    5/13/26 5:03:17 PM ET
    $NHP

    $NHP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Michelson Leslie D

    4 - National Healthcare Properties, Inc. (0001561032) (Issuer)

    5/19/26 5:30:36 PM ET
    $NHP

    SEC Form 4 filed by Director Humphrey Scott

    4 - National Healthcare Properties, Inc. (0001561032) (Issuer)

    5/19/26 5:29:25 PM ET
    $NHP

    SEC Form 4 filed by Director Weil Edward M Jr.

    4 - National Healthcare Properties, Inc. (0001561032) (Issuer)

    5/19/26 5:28:21 PM ET
    $NHP

    $NHP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on National Healthcare Properties with a new price target

    Citizens initiated coverage of National Healthcare Properties with a rating of Mkt Outperform and set a new price target of $18.00

    5/28/26 8:57:03 AM ET
    $NHP

    KeyBanc Capital Markets initiated coverage on National Healthcare Properties

    KeyBanc Capital Markets initiated coverage of National Healthcare Properties with a rating of Sector Weight

    5/18/26 8:36:12 AM ET
    $NHP

    RBC Capital Mkts initiated coverage on National Healthcare Properties with a new price target

    RBC Capital Mkts initiated coverage of National Healthcare Properties with a rating of Sector Perform and set a new price target of $15.00

    5/18/26 8:35:30 AM ET
    $NHP

    $NHP
    Financials

    Live finance-specific insights

    View All

    National Healthcare Properties Announces Release Date for First Quarter 2026 Results

    NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHP) ("NHP") announced today that it will release its financial results for the quarter ended March 31, 2026 after market close on Wednesday, May 13, 2026. NHP's executive leadership will also host a conference call and webcast on Thursday, May 14, 2026, beginning at 2:00 p.m. ET, to review the first quarter results. The dial in numbers for the conference call are 1-833-461-5787 (U.S & Canada) and +1-585-542-9983 (International) and the Meeting ID is 768836481. Alternatively, you can pre-register for the call here. Upon pre-registering for the call, a unique dial-in code will be emailed directly to yo

    5/1/26 8:29:49 AM ET
    $NHP